BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8743646)

  • 1. Improvement of debilitating tardive dyskinesia with risperidone.
    Rangwani SR; Gupta S; Burke WJ; Potter J
    Ann Clin Psychiatry; 1996 Mar; 8(1):27-9. PubMed ID: 8743646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of tardive dyskinesia with risperidone: a case report.
    Kooptiwoot S; Settachan T
    J Med Assoc Thai; 2000 Nov; 83(11):1430-2. PubMed ID: 11215878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia.
    Chan HY; Chiang SC; Chang CJ; Gau SS; Chen JJ; Chen CH; Hwu HG; Lai MS
    J Clin Psychiatry; 2010 Sep; 71(9):1226-33. PubMed ID: 20441726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
    Peritogiannis V; Tsouli S
    J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study.
    Bai YM; Yu SC; Chen JY; Lin CY; Chou P; Lin CC
    Int Clin Psychopharmacol; 2005 Mar; 20(2):79-85. PubMed ID: 15729082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice.
    Carvalho RC; Silva RH; Abílio VC; Barbosa PN; Frussa-Filho R
    Brain Res Bull; 2003 Apr; 60(1-2):115-24. PubMed ID: 12725899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
    Jeste DV; Okamoto A; Napolitano J; Kane JM; Martinez RA
    Am J Psychiatry; 2000 Jul; 157(7):1150-5. PubMed ID: 10873925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone treatment of tardive dyskinesia and dystonia.
    Chong SA; Remington G; Tan CH
    J Clin Psychiatry; 1999 May; 60(5):340-1. PubMed ID: 10362448
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone for tardive dyskinesia.
    Chen JY; Bai YM; Pyng LY; Lin CC
    Am J Psychiatry; 2001 Nov; 158(11):1931-2. PubMed ID: 11691710
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
    Bressan RA; Jones HM; Pilowsky LS
    J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone-induced tardive dyskinesia.
    Silberbauer C
    Pharmacopsychiatry; 1998 Mar; 31(2):68-9. PubMed ID: 9562211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
    Peritogiannis V; Tsouli S
    J Clin Psychiatry; 2011 Jul; 72(7):1016; author reply 1016-7. PubMed ID: 21824463
    [No Abstract]   [Full Text] [Related]  

  • 14. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction.
    Anand VS; Dewan MJ
    Ann Clin Psychiatry; 1996 Sep; 8(3):179-82. PubMed ID: 8899136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone, tardive dyskinesia, and the elderly.
    Chaplin RH
    Am J Psychiatry; 2001 Aug; 158(8):1336-7. PubMed ID: 11481187
    [No Abstract]   [Full Text] [Related]  

  • 17. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
    Khan BU
    J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
    Nelson MW; Reynolds RR; Kelly DL; Conley RR
    Clin Neuropharmacol; 2003; 26(6):297-8. PubMed ID: 14646608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of clonazepam in an elderly bipolar patient with tardive dyskinesia: a case report.
    Gerding LB; Labbate LA
    Ann Clin Psychiatry; 1999 Jun; 11(2):87-9. PubMed ID: 10440526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.